Cellectis (CLLS) Operating Margin Growth (5y) (2020 - 2026)
Cellectis (CLLS) Operating Margin Growth (5y) (2020 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
| 10 |
Cellectis |
17.40 Bn |
17.21 Bn |
- |
| Date | Value |
|---|
| Mar 31, 2026 |
-35,788.00 |
| Dec 31, 2025 |
11,408.00 |
| Sep 30, 2025 |
49,791.00 |
| Jun 30, 2025 |
108,168.00 |
| Mar 31, 2025 |
-16,182.00 |
| Dec 31, 2024 |
81,806.00 |
| Sep 30, 2024 |
24,755.00 |
| Jun 30, 2024 |
283,562.00 |
| Mar 31, 2024 |
177,012.00 |
| Dec 31, 2023 |
-742,870.00 |
| Sep 30, 2023 |
-1.01 Mn |
| Jun 30, 2023 |
-1.30 Mn |
| Mar 31, 2023 |
-1.64 Mn |
| Dec 31, 2022 |
36,644.00 |
| Sep 30, 2022 |
-1.52 Mn |
| Jun 30, 2022 |
-178,408.00 |
| Mar 31, 2022 |
-146,237.00 |
| Dec 31, 2021 |
-13,542.00 |
| Sep 30, 2021 |
-39,522.00 |
| Jun 30, 2021 |
-28,014.00 |
